Myricx Bio has a total of 53 patents globally, out of which 2 have been granted. Of these, around 83.01% patents are active. Myricx Bio has filed the maximum number of patents, followed by the United States and United Kingdom. Parallelly, United Kingdom also serves as the company’s primary R&D hub and country of origin.
Founded in 2019, Myricx Bio is a clinical-stage biotechnology company focused on developing next-generation antibody-drug conjugates (ADCs) for the treatment of cancer. Its pipeline includes innovative ADC candidates targeting solid tumors by leveraging its proprietary N-Myristoyltransferase inhibitor (NMTi) payload technology. The company is committed to developing highly differentiated cancer therapies with improved efficacy, enhanced tumor selectivity, and better safety profiles, aiming to address significant unmet needs in oncology.
In July 2026, Novartis agreed to acquire Myricx Bio for up to $1.5 billion to strengthen its oncology pipeline and advance next-generation antibody-drug conjugate (ADC) therapies powered by Myricx Bio’s novel NMTi payload platform.
Do read about some of the most notable patents of Myricx Bio covered in this article. You can also explore Myricx Bio’ patent portfolio, worldwide patent filing activity, patent filing trends over the years, and many other statistics related to its patent portfolio.
How many patents does Myricx Bio have?
Myricx Bio has a total of 53 patents globally. These patents belong to 7 unique patent families. Out of 53 patents, 44 patents are active.
How Many Patents did Myricx Bio File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Myricx Bio Applications Filed | Myricx Bio Patents Granted |
| 2026 | 1 | 2 |
| 2025 | 14 | – |
| 2024 | 2 | – |
| 2023 | 28 | – |
| 2022 | 1 | – |
| 2021 | 6 | – |
| 2020 | 1 | – |
How many Myricx Bio patents are Alive/Dead?
Worldwide Patents
How Many Patents did Myricx Bio File in Different Countries?
Countries in which Myricx Bio Filed Patents
| Country | Patent |
| United States of America | 6 |
| United Kingdom | 6 |
| Europe (EPO) | 5 |
| Canada | 3 |
| India | 3 |
| Hong Kong (S.A.R.) | 3 |
| Korea (South) | 3 |
| Mexico | 2 |
| South Africa | 2 |
| Singapore | 2 |
| Israel | 2 |
| Brazil | 2 |
| Australia | 2 |
| Eurasia | 2 |
| Indonesia | 1 |
| Taiwan | 1 |
| New Zealand | 1 |
| Chile | 1 |
| Philippines | 1 |
| Saudi Arabia | 1 |
Stay Updated on Patent Activity
Patent activity moves fast. With Elixir, monitor new filings, track competitors, and get timely alerts on critical IP developments. Book an Elixir Demo
Where are Research Centres of Myricx Bio Patents Located?
What are Myricx Bio key innovation segments?
What Technologies are Covered by Myricx Bio?
The chart below distributes patents filed by Myricx Bio